Sangui Bio team
Dr. Ben Herbert
40 years experience in protein chemistry and proteomics. Co-founder of two ASX-listed companies (Proteome Systems, Regeneus). H-index 41, 100+ publications, 7,400+ citations.
Alan Liddle
Senior executive with extensive experience in capital raising, governance and biotech commercialisation across listed and private companies.
Dr. Elisabeth Karsten
PhD biochemist whose work established that red blood cells are dynamic reservoirs of cytokines, a foundational discovery underpinning Sangui Bio's platform.
Cameron Hill
Over ten years of commercial and academic research experience. BSc majoring in biochemistry / pharmacology with honours in biochemistry.
Natasha Lucas
15+ years experience in pharmaceutical, toxicological and proteomic applications of mass spectrometry.
Rosalee McMahon
BSc and Diploma of Education. Worked in science education for three years across Sydney and London before joining Sangui Bio.
Carl Stubbings
Senior leader in biotechnology and diagnostics with deep experience in commercialisation, sales, marketing and business development.
Dr. Michael Ellies
Director with experience across healthcare, government, financial services, media and not-for-profit sectors.
Dr. Benjamin Chen
Life sciences executive with venture capital experience and a background in cell biology and immunology.
Lisa Moore
Company secretary with experience supporting governance and compliance in growing biotech businesses.